Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Valdecoxib

A selective COX-2 inhibitor among the non-steroidal anti-inflammatory drugs, approved in the United States in 2001 for osteoarthritis, rheumatoid arthritis and menstrual pain; it was withdrawn from the market in 2005. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?It lives on through parecoxib, a water-soluble injectable prodrug approved in Europe in 2002 for post-operative pain, which the body converts into valdecoxib itself.

ValdecoxibGo to the active ingredient →
ValdecoxibActive ingredientValdecoxibCat. No. P-V005-001CAS 181695-72-7
Valdecoxib-d3Isotopically labelledValdecoxib-d3Cat. No. P-V005-002CAS 1219794-90-7

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.